School of Medicine
Showing 2,081-2,100 of 13,047 Results
-
Megan Christofferson
Department Fellowship Manager, Peds/Education, Engagement and Opportunity
Current Role at StanfordDepartment Fellowship Manager, Department of Pediatrics
-
Antonios Chronopoulos
Instructor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research focuses on understanding how extracellular matrix (ECM) remodeling in liver fibrosis, particularly in the context of aging, diabetes, and metabolic-associated steatohepatitis (MASH), disrupts tissue mechanical homeostasis and drives hepatocellular carcinoma pathogenesis. The goal is to translate these mechanobiological insights into novel therapies targeting mechanotransduction to prevent or reverse fibrosis and improve patient outcomes with liver cancer and other desmoplastic tumors
-
Alvina Dor-Yan Chu
Adjunct Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioAlvina Chu, MD, is an adjunct clinical faculty member within the Division of Immunology and Rheumatology. She has practiced rheumatology for more than 10 years, specializing in treatment of a wide range of chronic inflammatory conditions including rheumatoid arthritis, lupus, vasculitis, and gout.
She holds a longstanding scientific interest in immunology, especially the role of B-cell signaling mechanisms in lupus and other autoimmune diseases.
In addition to taking care of patients in clinic and in the hospital, Dr. Chu enjoys teaching and mentoring fellows, residents, and medical students. -
Andrew Chu, MD, MPH, MBA
Clinical Assistant Professor, Emergency Medicine
BioDr. Chu is a board-certified emergency medicine physician and clinical assistant professor in the Department of Emergency Medicine. He is passionate about integrating lean startup methodologies into daily academic practice and has a decade of experience leading multi-disciplinary teams in designing, developing, and launching award-winning healthcare technologies. Dr. Chu is currently working with his colleagues to build AI solutions that will improve clinical operations for the emergency department.
He is also part of the Stanford EM Partners Program (STEPP), where he evaluates and executes on promising academic-industry partnerships. He is also an active committee member and former co-chair for the Stanford EM Innovation Conference, the premier virtual conference on AI and innovation for the acute care space.
He completed his residency in emergency medicine at the Harvard affiliated Mass General Brigham program. He received his applied research fellowship in healthcare innovation at Harvard Medical School. He also completed the Stanford Biodesign Faculty Fellowship. He pursued a medical degree at Boston University, a Master of Public Health (MPH) degree at Harvard, and a Master of Business Administration (MBA) degree at the Quantic School of Business and Technology.
He is a member of the American College of Emergency Physicians, American Academy of Emergency Medicine, and Society of Academic Emergency Medicine. -
Constance Chu, MD
Elsbach-Richards Professor of Surgery
BioDr. Constance R. Chu is Professor and Vice Chair Research, in the Department of Orthopedic Surgery at Stanford University. She is also Director of the Joint Preservation Center and Chief of Sports Medicine at the VA Palo Alto. Previously, she was the Albert Ferguson Endowed Chair and Professor of Orthopaedic Surgery at the University of Pittsburgh. She is a clinician-scientist who is both principal investigator of several projects funded by the National Institutes of Health and who has been recognized as a Castle-Connelly/US News and World Report “Top Doctor” in Orthopedic Surgery as well as on Becker’s list of Top Knee Surgeons in the United States. Her clinical practice focuses on the knee: primarily restoration and reconstruction of the ACL, menisci and cartilage. She graduated from the U.S. Military Academy at West Point and earned her medical degree from Harvard Medical School.
As Director of the multi-disciplinary Joint Preservation Center structured to seamlessly integrate the latest advances in biologics, mechanics, and imaging with comprehensive patient centered musculoskeletal and orthopedic care, Dr. Chu aims to develop a new model for health care delivery, research and education with an emphasis on health promotion and prevention. Cornerstones of this program include teamwork and a focus on personalized medicine. A central goal is to transform the clinical approach to osteoarthritis from palliation to prevention. In addition to optimizing clinical operations, outstanding research is critical to developing more effective new treatments. Towards this end, Dr. Chu is leading innovative translational research from bench to bedside in three main areas: quantitative imaging and biomarker development for early diagnosis and staging of joint and cartilage injury and degeneration; cartilage tissue engineering and stem cell based cartilage repair; and molecular and biological therapies for joint restoration and joint rejuvenation. Her research efforts have led to more than 30 professional awards and honors to include a Kappa Delta Award, considered to be the highest research honor in Orthopedic Surgery.
Dr. Chu also regularly holds leadership and committee positions in major professional organizations such as the American Association of Orthopedic Surgeons (AAOS) and the American Orthopedic Association (AOA). In her subspecialty of Orthopedic Sports Medicine, she is a past President of the Forum Sports Focus Group, a member of the Herodicus Society of leaders in Sports Medicine, and immediate past Chair of the American Orthopedic Society for Sports Medicine (AOSSM) Research Council. She is alumnus of the AOA American, British, Canadian (ABC) and the AOSSM Traveling Fellowships. -
David Chu
Veterinarian, Comparative Medicine - Veterinary Service Center
Current Role at StanfordOversee day to day operations in rodent and aquatic animal health programs including clinical medicine, health surveillance, import / export affairs, and strategic planning spreading across over a dozen facilities on and off campus. Supervise personnel engaged in rodent health surveillance enterprise. Administer veterinary care to animals in AAALAC-accredited Stanford research colonies. Participate in clinical and didactic training of residents (ACLAM sanctioned), externs, and visiting veterinary students. Provide assessments of animals prior to intrastate, interstate, and international shipments, including physical examination, review of colony history, and pertinent diagnostic tests. Review animal care and use proposals for the IACUC and coordinate the monitoring of approved research projects.
-
Derek Chu, MD
Clinical Associate Professor, Dermatology
BioDerek Chu, M.D., is Clinical Associate Professor of Dermatology and Pediatrics at Lucile Packard Children's Hospital. He completed his medical school and residency training at the University of Pennsylvania, followed by a pediatric dermatology fellowship at UCSF. Dr. Chu's clinical interests encompass a wide array of topics within pediatric dermatology, including vascular tumors and malformations, inflammatory skin diseases, dermato-oncology, neonatal dermatology, and procedural dermatology.
Email: derekchu@stanford.edu -
Gilbert Chu
Professor of Medicine (Oncology) and of Biochemistry
Current Research and Scholarly InterestsAfter shuttering the wet lab, we have focused on: a point-of-care device to measure blood ammonia and prevent brain damage; a human protein complex that juxtaposes and joins DNA ends for repair and V(D)J recombination; and strategies for teaching students and for reducing selection bias in educational programs.
-
Isabella Chu
Associate Director of Research Data Administration and Compliance, Center for Population Health Sciences
BioI have been with the Stanford School of Medicine since 2001. I received my MPH in Public Health from UC Berkeley in 2011 and joined The Stanford Center for Population Health Sciences (PHS) in 2016. My research interests focus on social and environmental determinants of health, particularly how the built environment, especially housing and transportation policy, promotes equitable access to the economy, education and other opportunities and can improve public health.
Road deaths have been the leading cause of child and young adult traumatic injury and death in the United States for many years and I want to better understand how better transportation policy can lead to safer streets for people on foot, bicycles and in automobiles.
I am the Associate Director of the Data Core at PHS. The PHS Data Core specializes in hosting large, rich, high risk data which are used by hundreds of researchers to answer questions in precision and population health. My primary responsibilities include overseeing governance and regulatory matters, data security, privacy and ethics and collaboration with the team of research scientists and engineers who have built the PHS Data Core platform. This platform and model have been replicated in several research universities throughout the United States.
Prior to joining PHS I initiated the Stanford Research Registry (SRR) which grew to over 4,000 members within two years and greatly facilitated research participation for both individuals with chronic disease as well as healthy controls in clinical trials and qualitative research. The SRR served as the foundation for the Patient Engagement Portal initiative which allows for bi-directional communication with the entire Stanford patient population and the general public for the purposes of recruitment for research, reporting research findings and allowing research participants to better understand the impacts of their service on the advancement of science. -
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD)
Current Research and Scholarly InterestsI have two lines of research, one involving educational informatics and use of technology in postgraduate medical education and another involving NIH-funded work in patient-oriented clinical research regarding opioid use and physiologic responses associated with acute and chronic exposure in humans.
For a full description of my educational informatics work, please see my website aim.stanford.edu.
My clinical research focuses on the study opiate-induced hyperalgesia in patients suffering from chronic pain.
I am currently conducting an NIH-funded five year double-blinded randomized controlled clinical study (NIGMS award 1K23GM071400-01) that prospectively examines the following hypotheses: 1) pain patients on chronic opioid therapy develop dose-dependent tolerance and/or hyperalgesia to these medications over time, 2) opiate-induced tolerance and hyperalgesia develop differently with respect to various types of pain, 3) opioid-induced hyperalgesia occurs independently of withdrawal phenomena, and 4) opiate-induced tolerance and hyperalgesia develop differently based on gender and/or ethnicity.
The study is the first quantitative and prospective examination of tolerance and hyperalgesia in pain patients and may have important implications for the rational use of opioids in the treatment of chronic pain. -
Steven Chu
William R. Kenan Jr. Professor, Professor of Molecular and Cellular Physiology and of Energy Science and Engineering
On Partial Leave from 2026-09-01 To 2027-08-31Current Research and Scholarly InterestsSynthesis, functionalization and applications of nanoparticle bioprobes for molecular cellular in vivo imaging in biology and biomedicine. Linear and nonlinear difference frequency mixing ultrasound imaging. Lithium metal-sulfur batteries, new approaches to electrochemical splitting of water. CO2 reduction, lithium extraction from salt water
-
Weihan Chu
Clinical Assistant Professor, Medicine
BioAlex Weihan Chu, M.D. is a Clinical Assistant Professor at Stanford University School of Medicine and Associate Chief Medical Officer and Vice President for Clinical Affairs, Quality, and Health Equity at Stanford Health Care – Tri-Valley.
Dr. Chu joined Tri-Valley as an academic hospitalist in 2015 after completing his internal medicine residency at Stanford. He served as a Clinical Instructor from 2015 to 2018 and has been a Clinical Assistant Professor since 2018. He is board-certified in Internal Medicine and Clinical Informatics and has served as Tri-Valley’s Medical Informatics Director since 2016.
In his current executive role, which began in 2024, Dr. Chu provides clinical leadership for medical staff quality, patient safety, and performance improvement. He chairs the Joint Quality Council, co-leads Unit-Based Medical Director engagement, and leads strategic work in employee engagement and physician wellness, community partnerships and health equity, and digital innovation. His responsibilities also include clinical affairs, specialty coverage planning, physician agreements, and directorships. In 2026, he became executive sponsor for Support Services II (Telecom, TDS, and BioMed) in the Highly Reliable Patient Centered Care management system launch.
Dr. Chu previously served as Associate Chief Medical Officer for Patient Safety, Infection Control, and Regulatory Compliance (2022–2024) and Vice Chief of Medicine (2021–2023). His work spans accreditation readiness, clinical documentation, transfusion safety, physician engagement, and clinical workflow redesign. He founded the Clinician Builder Program in 2019 and the Health Information Management Services Committee in 2020. His projects include telemedicine services, digital procedure consents, clinical decision support, order set optimization, and support for the Tri-Valley neurosurgery program launch planned for December 2026.
Dr. Chu is a reviewer for Applied Clinical Informatics and received the Division of Hospital Medicine’s Excellence in Interprofessional Practice Award in 2025. His professional development includes the Stanford Leadership Development Program (2024) and the Just Culture Conduct Course for Healthcare Managers & Influencers offered by The Just Culture Company (2026).
Outside of work, Dr. Chu enjoys hiking, scuba diving, photography, and exploring advancements in technology. -
Ian Chua
Clinical Associate Professor, Pediatrics
BioIan Chua, MD, MHPE, MBA is a bicoastal pediatric hospitalist and clinical associate professor of pediatrics at Stanford Children’s Health (Palo Alto, CA) and Children’s National Medical Center (Washington, DC). He completed his residency at Stanford Children’s with concentrations in medical education and quality improvement. He obtained his Masters’ in Health Professions Education at University of Illinois in Chicago. He currently co-directs the Quality and Leadership Training (QUILT) program in the department of pediatrics as well as the PHM Leadership Rotation. He also directs the ACGME Fellows’ Common Core Curriculum, the PHM Fellowship Medical Education Pathway, and the Pediatric residency medical education pathway at Children’s National Medical Center. His interests have been in educational scholarship and professional development of transitional learners including junior faculty. Nationally, he has been involved in shaping the national PHM fellows' conference and is the current co-chair for the AAP SOHM Emerging Leaders Conference.
-
Katrin Chua
Professor of Medicine (Endocrinology, Gerontology and Metabolism)
Current Research and Scholarly InterestsOur lab is interested in understanding molecular processes that underlie aging and age-associated pathologies in mammals. We focus on a family of genes, the SIRTs, which regulate stress resistance and lifespan in lower organisms such as yeast, worms, and flies. In mammals, we recently uncovered a number of ways in which SIRT factors may contribute to cellular and organismal aging by regulating resistance to various forms of stress. We have now begun to characterize the molecular mechanisms by which these SIRT factors function. In particular, we are interested in how SIRT factors regulate chromatin, the molecular structure in which the DNA of mammalian genomes is packaged, and how such functions may link genome maintenance to stress resistance and aging.
